Dr. Herbst on MPDL3280A for Non-Small Cell Lung Cancer

1 Views
administrator
administrator
07/14/23

Roy S. Herbst, MD, PhD, a professor of Medicine at Yale Cancer Center and chief of Medical Oncology at Smilow Cancer Hospital at Yale-New Haven in Connecticut, comments on the emergence of immunotherapies for multiple types of cancer including MPDL3280A for non-small cell lung cancer.

For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next